The Pelvic Floor Muscle Function in Chinese Primipara, a One-year Cohort Study

May 10, 2018 updated by: Peking Union Medical College Hospital
It is a prospective cohort study.The primiparas in six geographic regions of China are recruited to observe the natural recovery of pelvic floor muscle. The pelvic floor muscle function is evaluated at 6 weeks,3 months and 12 months after delivery.

Study Overview

Detailed Description

The primiparas in six geographic regions of China are recruited to observe the natural recovery of pelvic floor muscle.Evaluation of pelvic floor function is performed at 6 weeks, 3 months, 12 months after delivery. The modified Oxford Grading Scale and Levator ani testing are used to quantify PFM strength through vaginal palpation. Pelvic floor muscles strength, endurance, repetition,vaginal contraction pressure and the knack test are evaluated using a neuromuscular stimulation therapy system of PHENIX (Company: Vivaltis -Electronic Concept Lignon Innovation, Montpellier, France).

Study Type

Observational

Enrollment (Anticipated)

3120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beiing
      • Beijing, Beiing, China, 100730
        • Recruiting
        • Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Six geographic regions of China are needed to be covered, and more than 1-2 hospitals in each area should be included. The primipara are recruited while having their routine follow-up 6 weeks after delivery at the outpatient department in local hospitals.

Description

Inclusion Criteria:

  1. Women who give birth for the first time (Including vaginal delivery and cesarean section)
  2. Term birth(37-42 weeks)
  3. Single birth
  4. Aged from 18 to 50
  5. Plan to live locally for extended periods of time

Exclusion Criteria:

  1. A history of incontinence before pregnancy
  2. A history of fecal incontinence before pregnancy
  3. Pelvic organ prolapse before pregnancy (prolapse out of the hymen )
  4. A history of abortion or induced labour over 16 weeks of pregnancy
  5. Multiple pregnancy
  6. The weight of the newborn is less than 2500g or more than 4000g
  7. Precipitate labour
  8. Operative vaginal delivery(obstetric forceps or vacuum extraction)
  9. Laceration of perineum at least level III
  10. Request for pelvic floor rehabilitation exercise(patients who have entered the group can not train the pelvic floor muscle)
  11. Obesity (BMI before pregnancy over 25, BMI=weight (kg) / height square (m2) )
  12. Asthma
  13. Long-term abdominal pressure(chronic cough for more than 1 months ,long-term constipation ect.)
  14. Diabetes
  15. Cotugno's disease
  16. A history of pelvic floor surgery in the previous years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum vaginal contraction pressure
Time Frame: Change from Baseline Maximum Vaginal Contraction Pressure in a year after delivery
it is measured by manometry, range(80-150cmH2O). The higher values represent better outcomes.
Change from Baseline Maximum Vaginal Contraction Pressure in a year after delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pelvic floor muscle strength
Time Frame: change from baseline in a year after delivery
The modified Oxford Grading Scale is used to quantify PFM strength through vaginal palpation.range(0-5).The higher values represent better outcomes.
change from baseline in a year after delivery
Pelvic floor muscle strength(repetition)
Time Frame: change from baseline in a year after delivery
Levator ani testing is used to quantify PFM strength.range(0-5).The higher values represent better outcomes.
change from baseline in a year after delivery
Pelvic floor muscle contraction edurance
Time Frame: change from baseline in a year after delivery
muscle contractions maintained for 0 s are defined as grade 0, 1 s as grade I, 2 s as grade II, 3 s as grade III, 4 s as grade IV, and 5 s or longer as grade V. Normal muscles can maintain the contraction for 5 s.range(0-5s).The higher values represent better outcomes.
change from baseline in a year after delivery
the knack test
Time Frame: change from baseline in a year after delivery
a voluntary PFM contraction before or during coughing.That the contraction could be performed represents normal.
change from baseline in a year after delivery
vaginal rest pressure
Time Frame: change from baseline in a year after delivery
measure when no vaginal contraction by manometry. range(25-50 cmH2O). the lower and the higher values represent abnormal outcomes.
change from baseline in a year after delivery
Condition of stress urinary incontinence
Time Frame: change from baseline in a year after delivery
Ingelman-Sundberg classification is used according to the clinical symptoms of urinary incontinence, divided into mild, moderate and severe.
change from baseline in a year after delivery
pelvic organ prolapse quantification(POP-Q)
Time Frame: change from baseline in a year after delivery
POP-Q is measured when maximum valsalva.range(0-4). stage 0 represents normal.
change from baseline in a year after delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2018

Primary Completion (Anticipated)

December 31, 2020

Study Completion (Anticipated)

December 31, 2020

Study Registration Dates

First Submitted

April 13, 2018

First Submitted That Met QC Criteria

April 23, 2018

First Posted (Actual)

April 24, 2018

Study Record Updates

Last Update Posted (Actual)

May 11, 2018

Last Update Submitted That Met QC Criteria

May 10, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Floor Muscle Weakness

3
Subscribe